Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FERMENTA BIOTECH LIMITED Capital/Financing Update 2022

Jun 14, 2022

60716_rns_2022-06-14_33a1389c-5317-48b2-94cd-0392b0c6eb94.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [486 x 66] intentionally omitted <==

Ref: F.No.:49

June 14, 2022

Corporate Relations, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400 001

Ref: Scrip Code: 506414

Dear Sirs,

Subject:

Update on the intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 – further extension of Validity Period of the Binding Term Sheet for Real Estate development of the Company.

Further to our earlier intimations, dated January 31, 2022 and April 14, 2022 regarding signing of Binding Term Sheet for Real Estate development of the Company and extension of Validity period of the Binding term Sheet respectively, and pursuant to Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby inform you that the Validity Period of the Binding Term Sheet between Fermenta Biotech Limited and Mextech Property Developers LLP dated January 31, 2022 has been further mutually extended from 135 days to 180 days.

Accordingly, within 180 days of the execution of the Binding Term Sheet, the parties would sign the Definitive Agreement in terms of the Binding Term Sheet.

This is for your information and records.

Thanking you,

Yours faithfully,

For Fermenta Biotech Limited

==> picture [88 x 47] intentionally omitted <==

Srikant N. Sharma Company Secretary CS Membership No: F3617

==> picture [60 x 61] intentionally omitted <==

==> picture [487 x 68] intentionally omitted <==